HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Syuan Li Selected Research

Neoplasms (Cancer)

10/2022ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Syuan Li Research Topics

Disease

6Thyroid Neoplasms (Thyroid Cancer)
12/2023 - 08/2019
1Neoplasms (Cancer)
10/2022
1Psychotic Disorders (Schizoaffective Disorder)
01/2018
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2018
1Autoimmune Diseases of the Nervous System
01/2018
1Schizophrenia (Dementia Praecox)
01/2018

Drug/Important Bio-Agent (IBA)

2Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2023 - 10/2022
1ErbB Receptors (EGF Receptor)IBA
12/2023
1Carrier Proteins (Binding Protein)IBA
12/2023
1IntegrinsIBA
10/2022
1NDI-091143IBA
10/2022
1Sorafenib (BAY 43-9006)FDA Link
10/2022
1LipidsIBA
10/2022
1Galectin 3 (LGALS3)IBA
01/2021
1CateninsIBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Chitinase-3-Like Protein 1IBA
10/2020
1Ethacridine (Ethacridine Lactate)IBA
08/2019
1Polytetrafluoroethylene (Teflon)FDA Link
01/2018
1AutoantibodiesIBA
01/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018